What is NandroMix 300?
NandroMix 300 combines two nandrolone esters in one oil: NPP (phenylpropionate, fast) and decanoate (long), 300mg/ml together. Nandrolone is a 19-nor steroid, classically used for mass building and joint comfort.
Anabolic steroid, not a peptide, ready to use.
Comparison
Two esters in one oil
The components and related mixes, as described in the TPD lexicon. Tap a card to open its entry.
In a direct comparison the level with phenylpropionate peaked earlier and higher, with decanoate suppression of own testosterone lasted longer. 2
How it works
Nandrolone binds the androgen receptor and promotes muscle building and nitrogen retention. It is considered comparatively mildly androgenic but can raise prolactin. The ester mix controls release: NPP acts fast, decanoate long.
As a 19-nor compound it strongly suppresses the body's own axis and may need a longer recovery.
Where it acts
Where nandrolone acted in trials
Tap a point or a card. All effects observed in trials with nandrolone decanoate, not with the mix.
- Skeletal muscle
Lean mass rose, on average 1.59 kg more than on placebo1
Observed in trials - Bone
Fewer new vertebral fractures in osteoporosis (21 vs 43%)7
Observed in trials - Liver
Raised liver enzymes in 88% in a 2-year trial8
Observed in trials - Skin
Acne in 59% in the same trial8
Observed in trials - Testes and hormone axis
Own testosterone suppressed, faster with phenylpropionate, longer with decanoate2
Observed in trials
Targets in the ChEMBL database13
Compound CHEMBL1200946: one recorded mechanism, Agonist, direct binding (both esters according to ChEMBL).
- Gene
- AR
- UniProt
- P10275
- ChEMBL
- CHEMBL1871
- Action
- Agonist, direct binding (both esters according to ChEMBL)
Use
Dosing
Dosing
Dosing, titration and syringe
Loading the dosing information …
- Getting started and stepping up, drawn as a staircase
- Units on the U-100 syringe for every step
- How long one vial lasts
What the research shows
A recent meta-analysis (Prokopidis, 2026) found that nandrolone decanoate modestly increases lean mass but does not reliably improve grip strength or bone density. It advised against routine clinical use. That is a sober read: effect on mass yes, clear functional benefit less so.
Study results
What the trials measured
Interactive: switch tabs, tap points, show or hide arms. Arms are named relative to each other, no dosing advice.
Lean mass with the decanoate component456
Change in kg from baseline, randomised trials with nandrolone decanoate
Each trial tested nandrolone decanoate only, not the mix. For the women the abstract gives no placebo value. The meta-analysis of 20 trials found 1.59 kg more than placebo.
New vertebral fractures in 2 years7
65 women over 70 with osteoporosis, nandrolone decanoate against placebo
Bone density at the lumbar spine and femoral neck rose by 3.7 and 4.7 percent over 2 years, haemoglobin by 14.3 percent. In the meta-analysis the effect on bone density was inconsistent.
Research status
Where the research stands
There is no study on the mix itself. Shown are registered trials on nandrolone decanoate, the registry lists none for nandrolone phenylpropionate. As of 26 Oct 2026. 12
- Preclinical Binding of nandrolone to the androgen receptor (rat, rabbit)
- Phase 1 no registered trial
- Phase 2 3 trials on components, 2 completed
- Phase 3 no registered trial
- Approval no study of the mix itself
Show all 6 trials on a timelineHide timeline
NCT02055456 · 20 participants, started Feb 2014, primary endpoint reached Feb 2017.
Registry entry ↗ · Results: Clé et al., Haematologica, 2023
HIP-SAP · NCT03545347 · 29 participants, started Sept 2018, primary endpoint reached May 2020.
Registry entry ↗ · Results not yet in PubMed
SARKOPENIA · NCT05978206 · 168 participants (planned), started Aug 2023, primary endpoint planned Dec 2026.
NCT00250536 · 80 participants, started Mar 2000, primary endpoint reached Oct 2004.
Registry entry ↗ · Results not yet in PubMed
Le-Na · NCT02376309 · 30 participants, started Aug 2015, primary endpoint reached Aug 2016. Tests several agents.
Registry entry ↗ · Results not yet in PubMed
NCT03263520 · 60 participants, started Feb 2016, primary endpoint reached Aug 2017. Tests several agents.
Registry entry ↗ · Results not yet in PubMed
Bar: start to primary endpoint (planned for running trials). Green = completed, blue = progress until 26 Oct 2026.
Side effects
- Possible prolactin rise (libido problems, "deca dick" is often reported, see cabergoline).
- Strong suppression of the body's own axis, longer recovery.
- In women virilization (partly irreversible), lipid shift.
Tolerability
Frequency in a trial with nandrolone decanoate
Out of 100 participants, how many had the event over 2 years. One group of 17 people without placebo, only the decanoate component was tested.
No event of grade 4 or higher. The study looked at people with rare telomere disorders, not at the mix.8
Practice
-
Keep an eye on prolactin, consider cabergoline if needed.
-
Dose low, plan a post-cycle.
-
Banned in official competition (WADA S1) and detectable for a very long time.
Storage
Store at room temperature, cool and protected from light, out of reach of children. Keep the original bottle closed and mind the expiry date.